Seasonal omalizumab reduces allergen-specific immunoglobulin E levels in patients with Japanese cedar pollinosis and asthma

Seasonal omalizumab reduces allergen-specific immunoglobulin E levels in patients with Japanese cedar pollinosis and asthma

Bibliographic Details
Main Authors:	S. Hamada, H. Yasuba
Format:	Article
Language:	English
Published:	Elsevier 2017-11-01
Series:	Revista Portuguesa de Pneumologia (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2173511517301288

Similar Items

Asthma in Patients With Japanese Cedar Pollinosis
by: Akihiko Tanaka, et al.
Published: (2012-01-01)

Anti-IgE Antibody Therapy for Japanese Cedar Pollinosis: Omalizumab Update
by: Kimihiro Okubo, et al.
Published: (2008-01-01)

Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy
by: Takashi Fujimura, et al.
Published: (2015-10-01)

Biomarkers for Allergen Immunotherapy in Cedar Pollinosis
by: Takao Fujisawa, et al.
Published: (2009-01-01)

Next-Generation Allergen-Specific Immunotherapy for Japanese Cedar Pollinosis Using Molecular Approaches
by: Takaiwa F
Published: (2021-07-01)

Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment
by: Toshihiro Osada, et al.
Published: (2021-07-01)

Clinical aspects of Japanese cedar pollinosis
by: Minoru Okuda, et al.
Published: (1998-01-01)

Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2009-01-01)

Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Minoru Gotoh, et al.
Published: (2005-01-01)

Allergen‐specific subcutaneous immunotherapy for Japanese cedar pollinosis decreases the number of metachromatic cells and eosinophils in nasal swabs during the preseason and in season
by: Kuninori Otsuka, et al.
Published: (2020-09-01)

Eicosanoids seasonally impact pulmonary function in asthmatic patients with Japanese cedar pollinosis
by: Tomoyuki Soma, et al.
Published: (2020-10-01)

The impact of co-existing seasonal allergic rhinitis caused by Japanese Cedar Pollinosis (SAR-JCP) upon asthma control status
by: Masayuki Hojo, et al.
Published: (2015-04-01)

Solid-in-Oil Nanodispersions for Transcutaneous Immunotherapy of Japanese Cedar Pollinosis
by: Qingliang Kong, et al.
Published: (2020-03-01)

Effect of fexofenadine on the quality of life of Japanese cedar pollinosis patients
by: Kimihiro Okubo, et al.
Published: (2004-01-01)

Serum Concentrations of Antigen-Specific IgG4 in Patients with Japanese Cedar Pollinosis
by: Shiori Kitaya, et al.
Published: (2021-07-01)

ALLERGEN-SPECIFIC IMMUNOTHERAPY IN CHILDREN WITH POLLINOSIS
by: R. M. Torshkhoeva, et al.
Published: (2014-01-01)

Association of Japanese cedar pollinosis and sensitization with HLA-DPB1 in the Japanese adolescent
by: Wataru Morii, et al.
Published: (2018-01-01)

The Relationship between Pollen Count Levels and Prevalence of Japanese Cedar Pollinosis in Northeast Japan
by: Kohei Honda, et al.
Published: (2013-01-01)

Are Respiratory Viruses Involved in Preseasonal Symptoms or Severity in Japanese Cedar Pollinosis?
by: Hirokuni Otsuka M.D., et al.
Published: (2016-06-01)

Two Thirds of Forest Walkers with Japanese Cedar Pollinosis Visit Forests even During the Pollen Season
by: Emi Morita, et al.
Published: (2009-01-01)

A novel approach of preventing Japanese cedar pollen dispersal that is the cause of Japanese cedar pollinosis (JCP) using pollen-specific fungal infection.
by: Yuuri Hirooka, et al.
Published: (2013-01-01)

Omalizumab is Effective and Safe in the Treatment of Japanese Cedar Pollen-induced Seasonal Allergic Rhinitis
by: Kimihiro Okubo, et al.
Published: (2006-01-01)

Determining Minimal Clinically Important Differences in Japanese Cedar/Cypress Pollinosis Patients
by: Takaya Higaki, et al.
Published: (2013-01-01)

Determining an Appropriate Time to Start Prophylactic Treatment with Intranasal Corticosteroids in Japanese Cedar Pollinosis
by: Takenori Haruna, et al.
Published: (2019-01-01)

Delay of Onset of Symptoms of Japanese Cedar Pollinosis by Treatment with a Leukotriene Receptor Antagonist
by: Minoru Gotoh, et al.
Published: (2011-01-01)

Patterns of Drug Prescription for Japanese Cedar Pollinosis Using a Clinical Vignette Questionnaire
by: Goro Takahashi, et al.
Published: (2008-01-01)

Effects of Pranlukast Hydrate on Airway Hyperresponsiveness in Non-Asthmatic Patients with Japanese Cedar Pollinosis
by: Hironori Sagara, et al.
Published: (2009-01-01)

An analysis of factors associated with compliance and dropout of sublingual immunotherapy on Japanese cedar pollinosis patients
by: Imanaka, Takahiro
Published: (2019)

Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy
by: Kuninori Otsuka, et al.
Published: (2020-09-01)

Inhibition of the Antigen Provoked Nasal Reaction by Second-generation Antihistamines in Patients with Japanese Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2006-01-01)

Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber)
by: Kazuhiro Hashiguchi, et al.
Published: (2017-01-01)

Preventative Effect of a Flavonoid, Enzymatically Modified Isoquercitrin on Ocular Symptoms of Japanese Cedar Pollinosis
by: Toru Hirano, et al.
Published: (2009-01-01)

Effect of concurrent administration of nobiletin and β-lactoglobulin on the symptoms of Japanese cedar pollinosis models in mice
by: Sho Yasunaga, et al.
Published: (2016-04-01)

Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial
by: Yasuyuki Nomura, et al.
Published: (2021-01-01)

Non-IgE,-IgG4 Antibody to Japanese Cedar Pollen Allergens:Comparison of Its Prevalence and Titers between Pollinosis Patients and Non-Patients
by: Hiroshi Miyazawa, et al.
Published: (2005-01-01)

Present Situation of Cedar Pollinosis in Japan and its Immune Responses
by: Yoshitaka Okamoto, et al.
Published: (2009-01-01)

Evaluation of Montelukast for the Treatment of Children With Japanese Cedar Pollinosis Using an Artificial Exposure Chamber (OHIO Chamber)
by: Kazuhiro Hashiguchi MD, et al.
Published: (2018-07-01)

Effect of intranasal corticosteroid on pre-onset activation of eosinophils and mast cells in experimental Japanese cedar pollinosis
by: Yasuyuki Noyama, et al.
Published: (2016-07-01)

Relationship between Airborne Cry j 1 and the Onset Time of the Symptoms of Japanese Cedar Pollinosis Patients
by: Yuichi Takahashi, et al.
Published: (2007-01-01)

Analysis of factors associated with cedar pollen sensitization and development of pollinosis in a young Japanese adult population
by: Satoshi Nakamura, et al.
Published: (2019-01-01)